Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Cangrelor. Nitrosamines are part of a broader class of compounds known as N-nitroso compounds. Cangrelor is an antiplatelet medication used for the prevention of blood clots, particularly in individuals undergoing percutaneous coronary intervention (PCI), a procedure to open narrowed or blocked arteries in the heart. Cangrelor belongs to the class of P2Y12 inhibitors and works by preventing platelets from aggregating and forming clots. Unlike oral P2Y12 inhibitors, cangrelor is administered intravenously and has a rapid onset of action. It is commonly used during PCI to reduce the risk of stent thrombosis and other cardiovascular events. As with any anticoagulant or antiplatelet medication, the use of cangrelor requires careful monitoring and should be managed by healthcare professionals to balance its benefits in preventing clots with the potential risk of bleeding complications.
Buy high quality N-Nitroso Cangrelor from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of N-Nitroso Cangrelor.

N-Nitroso Cangrelor

CAT. No. CP-C114001
CAS. No. NA
Mol. F. C17H24Cl2F3N6O13P3S2
Mol. Wt. 805.34
Stock Status Please Enquire

Product Description


  • Category:Impurity Standards
  • Chemical Name:(dichloro((((((2S,3R,4S,5S)-3,4-dihydroxy-5-(6-((2-(methylthio)ethyl)(nitroso)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)methyl)phosphonic acid

Request for Quotation : N-Nitroso Cangrelor

Please enter pack size
Please enter quantity
Please enter phone number
Enter 10 digit contact number
Enter only number
Please enter your full name
Please enter only alphabets
Please enter company name
Please enter your valid email
Please enter your valid email id
Please select country
Please select state
Please select city

Please select captcha
Please wait...